GlassScriptPhysician profile
Gary J Schwartz
NPI 1598879231
$2,744.12
in general payments reported to CMS, 2019-2025
21 companies · $104 in 2025
The $104 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
See the full distribution for Gastroenterology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,591 · 2020: $426 · 2021: $135 · 2022: $12.72 · 2023: $43.27 · 2024: $432 · 2025: $104.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $331 · Travel and Lodging: $249.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $330.86 |
| Travel and Lodging | $248.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $506.76 | 2019-2020 | |
| Abbvie INC. | $495.99 | 2019-2020 | |
| Pacira Pharmaceuticals Incorporated | $475.62 | 2023-2024 | Iovera, Exparel |
| Ferring Pharmaceuticals INC. | $156.91 | 2019-2020 | |
| Qol Medical, LLC | $146.47 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $143.56 | 2019-2020 | |
| Janssen Biotech, INC. | $143.01 | 2019 | |
| Vertos Medical, INC. | $135.15 | 2021 | |
| Allergan, INC. | $124.19 | 2019 | |
| Medtronic, INC. | $103.81 | 2025 | Intellis Adaptivestim |
| Pfizer INC. | $82.01 | 2019-2020 | |
| Daiichi Sankyo INC. | $68.24 | 2019 | |
| Braintree Laboratories, INC. | $27.91 | 2019-2020 | |
| Nestle Healthcare Nutrition INC. | $25.58 | 2020 | |
| Intercept Pharmaceuticals, INC. | $22.89 | 2020 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cumberland Pharmaceuticals, INC. | $20.15 | 2019 | |
| Redhill Biopharma INC. | $14.71 | 2020 | |
| Janssen Scientific Affairs, LLC | $14.18 | 2020 | |
| E.R. Squibb & Sons, L.L.C. | $12.72 | 2022 | |
| Shionogi INC | $12.53 | 2019 | |
| Ironwood Pharmaceuticals, INC | $11.73 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gary Schwartz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.